{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:36:41Z","timestamp":1761676601660,"version":"3.37.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T00:00:00Z","timestamp":1523491200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012152","name":"National Postdoctoral Program for Innovative Talents","doi-asserted-by":"crossref","award":["BX201600033"],"award-info":[{"award-number":["BX201600033"]}],"id":[{"id":"10.13039\/501100012152","id-type":"DOI","asserted-by":"crossref"}]},{"name":"China Postdoctoral Science Foundation Funded Project","award":["2017M611451"],"award-info":[{"award-number":["2017M611451"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cheminform"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13321-018-0275-x","type":"journal-article","created":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T08:49:42Z","timestamp":1523522982000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Finding the molecular scaffold of nuclear receptor inhibitors through high-throughput screening based on proteochemometric modelling"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2619-0298","authenticated-orcid":false,"given":"Tianyi","family":"Qiu","sequence":"first","affiliation":[]},{"given":"Dingfeng","family":"Wu","sequence":"additional","affiliation":[]},{"given":"Jingxuan","family":"Qiu","sequence":"additional","affiliation":[]},{"given":"Zhiwei","family":"Cao","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,4,12]]},"reference":[{"issue":"4854","key":"275_CR1","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1126\/science.3283939","volume":"240","author":"RM Evans","year":"1988","unstructured":"Evans RM (1988) The steroid and thyroid-hormone receptor superfamily. Science 240(4854):889\u2013895","journal-title":"Science"},{"issue":"40","key":"275_CR2","doi-asserted-by":"publisher","first-page":"36863","DOI":"10.1074\/jbc.R100047200","volume":"276","author":"JM Olefsky","year":"2001","unstructured":"Olefsky JM (2001) Nuclear receptor minireview series. J Biol Chem 276(40):36863\u201336864","journal-title":"J Biol Chem"},{"issue":"4","key":"275_CR3","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2174\/1568010042634541","volume":"3","author":"N Novac","year":"2004","unstructured":"Novac N, Heinzel T (2004) Nuclear receptors: overview and classification. Curr Drug Targets Inflamm Allergy 3(4):335\u2013346","journal-title":"Curr Drug Targets Inflamm Allergy"},{"issue":"12","key":"275_CR4","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/nrd2199","volume":"5","author":"JP Overington","year":"2006","unstructured":"Overington JP, Al-Lazikani B, Hopkins AL (2006) Opinion\u2014how many drug targets are there? Nat Rev Drug Discov 5(12):993\u2013996","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"275_CR5","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.febslet.2009.12.020","volume":"584","author":"HC Dorfmueller","year":"2010","unstructured":"Dorfmueller HC, van Aalten DMF (2010) Screening-based discovery of drug-like O-GlcNAcase inhibitor scaffolds. FEBS Lett 584(4):694\u2013700","journal-title":"FEBS Lett"},{"issue":"38","key":"275_CR6","doi-asserted-by":"publisher","first-page":"4224","DOI":"10.2174\/138161211798999366","volume":"17","author":"JA Camarero","year":"2011","unstructured":"Camarero JA (2011) Novel peptide-based scaffolds for drug discovery. Curr Pharm Des 17(38):4224\u20134225","journal-title":"Curr Pharm Des"},{"key":"275_CR7","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ejmech.2016.08.026","volume":"124","author":"CF Chang","year":"2016","unstructured":"Chang CF, Lin WH, Ke YY, Lin YS, Wang WC, Chen CH, Kuo PC, Hsu JTA, Uang BJ, Hsieh HP (2016) Discovery of novel inhibitors of Aurora kinases with indazole scaffold: in silico fragment-based and knowledge-based drug design. Eur J Med Chem 124:186\u2013199","journal-title":"Eur J Med Chem"},{"issue":"12","key":"275_CR8","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1021\/acsmedchemlett.6b00235","volume":"7","author":"Y Ge","year":"2016","unstructured":"Ge Y, Jin Y, Wang C, Zhang J, Tang Z, Peng J, Liu K, Li Y, Zhou Y, Ma X (2016) Discovery of novel Bruton\u2019s Tyrosine Kinase (BTK) inhibitors bearing a N,9-diphenyl-9H-purin-2-amine Scaffold. ACS Med Chem Lett 7(12):1050\u20131055","journal-title":"ACS Med Chem Lett"},{"issue":"7","key":"275_CR9","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1021\/acschembio.6b00159","volume":"11","author":"P Lu","year":"2016","unstructured":"Lu P, Liu X, Yuan X, He M, Wang Y, Zhang Q, Ouyang PK (2016) Discovery of a novel NEDD8 activating enzyme inhibitor with piperidin-4-amine Scaffold by structure-based virtual screening. ACS Chem Biol 11(7):1901\u20131907","journal-title":"ACS Chem Biol"},{"issue":"24","key":"275_CR10","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1002\/cmdc.201600446","volume":"11","author":"Z Shiokawa","year":"2016","unstructured":"Shiokawa Z, Kashiwabara E, Yoshidome D, Fukase K, Inuki S, Fujimoto Y (2016) Discovery of a novel Scaffold as an indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor based on the pyrrolopiperazinone alkaloid. Longamide B ChemMedChem 11(24):2682\u20132689","journal-title":"Longamide B ChemMedChem"},{"issue":"5389","key":"275_CR11","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1126\/science.282.5389.737","volume":"282","author":"SP Rohrer","year":"1998","unstructured":"Rohrer SP, Birzin ET, Mosley RT, Berk SC, Hutchins SM, Shen DM, Xiong YS, Hayes EC, Parmar RM, Foor F et al (1998) Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry. Science 282(5389):737\u2013740","journal-title":"Science"},{"issue":"4","key":"275_CR12","first-page":"764","volume":"21","author":"GD Geromichalos","year":"2016","unstructured":"Geromichalos GD, Alifieris CE, Geromichalou EG, Trafalis DT (2016) Overview on the current status of virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part I. J Buon 21(4):764\u2013779","journal-title":"J Buon"},{"issue":"4","key":"275_CR13","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.drudis.2017.02.004","volume":"22","author":"M Cruz-Monteagudo","year":"2017","unstructured":"Cruz-Monteagudo M, Schurer S, Tejera E, Perez-Castillo Y, Medina-Franco JL, Sanchez-Rodriguez A, Borges F (2017) Systemic QSAR and phenotypic virtual screening: chasing butterflies in drug discovery. Drug Discov Today 22(4):994\u20131007","journal-title":"Drug Discov Today"},{"issue":"1","key":"275_CR14","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1021\/jm0493921","volume":"48","author":"R Ragno","year":"2005","unstructured":"Ragno R, Frasca S, Manetti F, Brizzi A, Massa S (2005) HIV-reverse transcriptase inhibition: inclusion of ligand-induced fit by cross-docking studies. J Med Chem 48(1):200\u2013212","journal-title":"J Med Chem"},{"issue":"4","key":"275_CR15","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1021\/jm0309856","volume":"47","author":"R Ragno","year":"2004","unstructured":"Ragno R, Mai A, Sbardella G, Artico M, Massa S, Musiu C, Mura M, Marturana F, Cadeddu A, La Colla P (2004) Computer-aided design, synthesis, and anti-HIV-1 activity in vitro of 2-alkylamino-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3H)-ones as novel potent non-nucleoside reverse transcriptase inhibitors, also active against the Y181C variant. J Med Chem 47(4):928\u2013934","journal-title":"J Med Chem"},{"issue":"10","key":"275_CR16","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1021\/acs.jcim.6b00038","volume":"56","author":"S Takeda","year":"2016","unstructured":"Takeda S, Kaneko H, Funatsu K (2016) Chemical-space-based de novo design method to generate drug like molecules. J Chem Inf Model 56(10):1885\u20131893","journal-title":"J Chem Inf Model"},{"issue":"5","key":"275_CR17","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1002\/adhm.201500634","volume":"5","author":"S Menegatti","year":"2016","unstructured":"Menegatti S, Zakrewsky M, Kumar S, De Oliveira JS, Muraski JA, Mitragotri S (2016) De novo design of skin-penetrating peptides for enhanced transdermal delivery of peptide drugs. Adv Healthc Mater 5(5):602\u2013609","journal-title":"Adv Healthc Mater"},{"key":"275_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/minf.201681031","volume":"36","author":"G Schneider","year":"2017","unstructured":"Schneider G, Funatsu K, Okuno Y, Winkler D (2017) De novo drug design\u2014Ye olde Scoring Problem Revisited. Mol Inform 36:1\u20132. \n                    https:\/\/doi.org\/10.1002\/minf.201681031","journal-title":"Mol Inform"},{"issue":"11","key":"275_CR19","doi-asserted-by":"publisher","first-page":"20927","DOI":"10.3390\/ijms151120927","volume":"15","author":"HD Xie","year":"2014","unstructured":"Xie HD, Qiu KX, Xie XG (2014) 3D QSAR studies, pharmacophore modeling and virtual screening on a series of steroidal aromatase inhibitors. Int J Mol Sci 15(11):20927\u201320947","journal-title":"Int J Mol Sci"},{"key":"275_CR20","doi-asserted-by":"publisher","first-page":"W609","DOI":"10.1093\/nar\/gkq300","volume":"38","author":"XF Liu","year":"2010","unstructured":"Liu XF, Ouyang SS, Yu BA, Liu YB, Huang K, Gong JY, Zheng SY, Li ZH, Li HL, Jiang HL (2010) PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach. Nucleic Acids Res 38:W609\u2013W614","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"275_CR21","doi-asserted-by":"publisher","first-page":"W356","DOI":"10.1093\/nar\/gkx374","volume":"45","author":"X Wang","year":"2017","unstructured":"Wang X, Shen YH, Wang SW, Li SL, Zhang WL, Liu XF, Lai LH, Pei JF, Li HL (2017) PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database. Nucleic Acids Res 45(W1):W356\u2013W360","journal-title":"Nucleic Acids Res"},{"key":"275_CR22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ejmech.2014.08.004","volume":"91","author":"HT Zhao","year":"2015","unstructured":"Zhao HT, Caflisch A (2015) Molecular dynamics in drug design. Eur J Med Chem 91:4\u201314","journal-title":"Eur J Med Chem"},{"issue":"6","key":"275_CR23","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1039\/C6MB00848H","volume":"13","author":"U Ndagi","year":"2017","unstructured":"Ndagi U, Mhlongo NN, Soliman ME (2017) The impact of Thr91 mutation on c-Src resistance to UM-164: molecular dynamics study revealed a new opportunity for drug design. Mol BioSyst 13(6):1157\u20131171","journal-title":"Mol BioSyst"},{"key":"275_CR24","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1021\/jm00336a001","volume":"7","author":"C Hansch","year":"1964","unstructured":"Hansch C, Steward AR (1964) The use of substituent constants in the analysis of the structure-activity relationship in penicillin derivatives. J Med Chem 7:691\u2013694","journal-title":"J Med Chem"},{"issue":"1","key":"275_CR25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1039\/C0MD00165A","volume":"2","author":"GJP Westen van","year":"2011","unstructured":"van Westen GJP, Wegner JK, IJzerman AP, van Vlijmen HWT, Bender A (2011) Proteochemometric modeling as a tool to design selective compounds and for extrapolating to novel targets. Medchemcomm 2(1):16\u201330","journal-title":"Medchemcomm"},{"issue":"1","key":"275_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/bib\/bbw004","volume":"18","author":"T Qiu","year":"2017","unstructured":"Qiu T, Qiu J, Feng J, Wu D, Yang Y, Tang K, Cao Z, Zhu R (2017) The recent progress in proteochemometric modelling: focusing on target descriptors, cross-term descriptors and application scope. Brief Bioinform 18(1):125\u2013136","journal-title":"Brief Bioinform"},{"key":"275_CR27","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/1471-2105-13-212","volume":"13","author":"DF Wu","year":"2012","unstructured":"Wu DF, Huang Q, Zhang YD, Zhang QC, Liu Q, Gao J, Cao ZW, Zhu RX (2012) Screening of selective histone deacetylase inhibitors by proteochemometric modeling. BMC Bioinform 13:212. \n                    https:\/\/doi.org\/10.1186\/1471-2105-13-212","journal-title":"BMC Bioinform"},{"issue":"1\u20132","key":"275_CR28","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0304-4165(00)00187-2","volume":"1525","author":"M Lapinsh","year":"2001","unstructured":"Lapinsh M, Prusis P, Gutcaits A, Lundstedt T, Wikberg JES (2001) Development of proteo-chemometrics: a novel technology for the analysis of drug\u2013receptor interactions. Bba-Gen Subjects 1525(1\u20132):180\u2013190","journal-title":"Bba-Gen Subjects"},{"key":"275_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1758-2946-6-35","volume":"6","author":"I Cortes-Ciriano","year":"2014","unstructured":"Cortes-Ciriano I, van Westen GJP, Lenselink EB, Murrell DS, Bender A, Malliavin T (2014) Proteochemometric modeling in a Bayesian framework. J Cheminform 6:35. \n                    https:\/\/doi.org\/10.1186\/1758-2946-6-35","journal-title":"J Cheminform"},{"issue":"1","key":"275_CR30","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.gene.2012.11.061","volume":"518","author":"J Gao","year":"2013","unstructured":"Gao J, Huang Q, Wu DF, Zhang QC, Zhang YD, Chen T, Liu Q, Zhu RX, Cao ZW, He Y (2013) Study on human GPCR-inhibitor interactions by proteochemometric modeling. Gene 518(1):124\u2013131","journal-title":"Gene"},{"issue":"1","key":"275_CR31","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1124\/mol.104.002857","volume":"67","author":"M Lapinsh","year":"2005","unstructured":"Lapinsh M, Veiksina S, Uhlen S, Petrovska R, Mutule I, Mutulis F, Yahorava S, Prusis P, Wikberg JES (2005) Proteochemometric mapping of the interaction of organic compounds with melanocortin receptor subtypes. Mol Pharmacol 67(1):50\u201359","journal-title":"Mol Pharmacol"},{"issue":"7","key":"275_CR32","doi-asserted-by":"publisher","first-page":"e41698","DOI":"10.1371\/journal.pone.0041698","volume":"7","author":"Q Huang","year":"2012","unstructured":"Huang Q, Jin HX, Liu Q, Wu Q, Kang H, Cao ZW, Zhu RX (2012) Proteochemometric modeling of the bioactivity spectra of HIV-1 protease inhibitors by introducing protein\u2013ligand interaction fingerprint. PLoS ONE 7(7):e41698. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0041698","journal-title":"PLoS ONE"},{"issue":"20","key":"275_CR33","doi-asserted-by":"publisher","first-page":"9369","DOI":"10.1016\/j.bmc.2008.08.081","volume":"16","author":"P Prusis","year":"2008","unstructured":"Prusis P, Lapins M, Yahorava S, Petrovska R, Niyomrattanakit P, Katzenmeier G, Wikberg JES (2008) Proteochemometrics analysis of substrate interactions with dengue virus NS3 proteases. Bioorgan Med Chem 16(20):9369\u20139377","journal-title":"Bioorgan Med Chem"},{"issue":"4","key":"275_CR34","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.bbrc.2013.03.139","volume":"434","author":"P Prusis","year":"2013","unstructured":"Prusis P, Junaid M, Petrovska R, Yahorava S, Yahorau A, Katzenmeier G, Lapins M, Wikberg JES (2013) Design and evaluation of substrate-based octapeptide and non substrate-based tetrapeptide inhibitors of dengue virus NS2B-NS3 proteases. Biochem Biophys Res Commun 434(4):767\u2013772","journal-title":"Biochem Biophys Res Commun"},{"key":"275_CR35","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/1471-2105-11-339","volume":"11","author":"M Lapins","year":"2010","unstructured":"Lapins M, Wikberg JES (2010) Kinome-wide interaction modelling using alignment-based and alignment-independent approaches for kinase description and linear and non-linear data analysis techniques. BMC Bioinform 11:339. \n                    https:\/\/doi.org\/10.1186\/1471-2105-11-339","journal-title":"BMC Bioinform"},{"issue":"11","key":"275_CR36","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1021\/ci400369z","volume":"53","author":"V Subrarnanian","year":"2013","unstructured":"Subrarnanian V, Prusis P, Pietila LO, Xhaard H, Wohlfahrt G (2013) Visually interpretable models of kinase selectivity related features derived from field-based proteochemometrics. J Chem Inf Model 53(11):3021\u20133030","journal-title":"J Chem Inf Model"},{"issue":"12","key":"275_CR37","doi-asserted-by":"publisher","first-page":"e14353","DOI":"10.1371\/journal.pone.0014353","volume":"5","author":"M Junaid","year":"2010","unstructured":"Junaid M, Lapins M, Eklund M, Spjuth O, Wikberg JES (2010) Proteochemometric modeling of the susceptibility of mutated variants of the HIV-1 virus to reverse transcriptase inhibitors. PLoS ONE 5(12):e14353. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0014353","journal-title":"PLoS ONE"},{"issue":"11","key":"275_CR38","doi-asserted-by":"publisher","first-page":"e27518","DOI":"10.1371\/journal.pone.0027518","volume":"6","author":"GJP Westen van","year":"2011","unstructured":"van Westen GJP, Wegner JK, Geluykens P, Kwanten L, Vereycken I, Peeters A, IJzerman AP, van Vlijmen HWT, Bender A,  (2011) Which compound to select in lead optimization? Prospectively validated proteochemometric models guide preclinical development. PLoS ONE 6(11):e27518. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0027518","journal-title":"PLoS ONE"},{"key":"275_CR39","doi-asserted-by":"crossref","unstructured":"Nanduri R, Bhutani I, Somavarapu AK, Mahajan S, Parkesh R, Gupta P (2015) ONRLDB-manually curated database of experimentally validated ligands for orphan nuclear receptors: insights into new drug discovery. Database-Oxford","DOI":"10.1093\/database\/bav112"},{"key":"275_CR40","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13321-015-0110-6","volume":"7","author":"A Lusci","year":"2015","unstructured":"Lusci A, Fooshee D, Browning M, Swamidass J, Baldi P (2015) Accurate and efficient target prediction using a potency-sensitive influence-relevance voter. J Cheminform 7:63. \n                    https:\/\/doi.org\/10.1186\/s13321-015-0110-6","journal-title":"J Cheminform"},{"issue":"2","key":"275_CR41","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1021\/ci500588j","volume":"55","author":"T Sander","year":"2015","unstructured":"Sander T, Freyss J, von Korff M, Rufener C (2015) DataWarrior: an open-source program for chemistry aware data visualization and analysis. J Chem Inf Model 55(2):460\u2013473","journal-title":"J Chem Inf Model"},{"issue":"Pt 6 No 1","key":"275_CR42","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1107\/S0907444902003451","volume":"58","author":"HM Berman","year":"2002","unstructured":"Berman HM, Battistuz T, Bhat TN, Bluhm WF, Bourne PE, Burkhardt K, Feng Z, Gilliland GL, Iype L, Jain S et al (2002) The Protein Data Bank. Acta Crystallogr Sect D Biol Crystallogr 58(Pt 6 No 1):899\u2013907","journal-title":"Acta Crystallogr Sect D Biol Crystallogr"},{"issue":"1","key":"275_CR43","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0022-2836(81)90087-5","volume":"147","author":"TF Smith","year":"1981","unstructured":"Smith TF, Waterman MS (1981) Identification of common molecular subsequences. J Mol Biol 147(1):195\u2013197","journal-title":"J Mol Biol"},{"issue":"23","key":"275_CR44","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1093\/bioinformatics\/btq572","volume":"26","author":"A Prlic","year":"2010","unstructured":"Prlic A, Bliven S, Rose PW, Bluhm WF, Bizon C, Godzik A, Bourne PE (2010) Pre-calculated protein structure alignments at the RCSB PDB website. Bioinformatics 26(23):2983\u20132985","journal-title":"Bioinformatics"},{"issue":"15","key":"275_CR45","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1021\/jm9602928","volume":"39","author":"GW Bemis","year":"1996","unstructured":"Bemis GW, Murcko MA (1996) The properties of known drugs. 1. Molecular frameworks. J Med Chem 39(15):2887\u20132893","journal-title":"J Med Chem"}],"container-title":["Journal of Cheminformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-018-0275-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13321-018-0275-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-018-0275-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T09:55:49Z","timestamp":1561370149000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcheminf.biomedcentral.com\/articles\/10.1186\/s13321-018-0275-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,12]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["275"],"URL":"https:\/\/doi.org\/10.1186\/s13321-018-0275-x","relation":{},"ISSN":["1758-2946"],"issn-type":[{"type":"electronic","value":"1758-2946"}],"subject":[],"published":{"date-parts":[[2018,4,12]]},"assertion":[{"value":"27 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"21"}}